"Through its Biodefense Division, DOR is developing biomedical countermeasures pursuant to the Project BioShield Act of 2004. DOR's biodefense products in development are recombinant subunit vaccines
designed to protect against the lethal effects of exposure to ricin toxin and botulinum toxin. DOR's ricin toxin vaccine, RiVax, has been shown to be well tolerated and immunogenic in a Phase 1 clinical trial in normal volunteers."
yeah. A remarkable coinkydink.